Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 14
Submit an article Journal homepage
86
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Excess of deaths for patients with plasma cell proliferative disorders as a result of the COVID-19 pandemic

Tom Dunnea Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, CanadaORCID Iconhttps://orcid.org/0000-0003-0596-3490
ORCID Icon,
Douglas Stewarta Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, CanadaORCID Iconhttps://orcid.org/0000-0001-5531-0960
ORCID Icon,
Holly Leea Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, Canada
,
Jason Taya Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, Canada
,
Peter Duggana Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, Canada
,
Sylvia McCullocha Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, Canada
,
Paola Neria Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, Canada;b Charbonneau Cancer Research Institute, Calgary, Canada
,
Nizar J. Bahlisa Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, Canada;b Charbonneau Cancer Research Institute, Calgary, Canada
&
Victor H. Jimenez-Zepedaa Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, Canada;b Charbonneau Cancer Research Institute, Calgary, CanadaCorrespondence[email protected]
 show all
Pages 3555-3557 | Received 13 Jun 2021, Accepted 09 Aug 2021, Published online: 26 Aug 2021

References

  • Wang Q, Berger NA, Xu R. Analyses of risk, racial disparity, and outcomes among US patients with cancer and COVID-19 infection. JAMA Oncol. 2021;7(2):220–227.
  • Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–337.
  • Zhang L, Zhu F, Xie L, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020;31(7):894–901.
  • Desai A, Gupta R, Advani S, et al. Mortality in hospitalized patients with cancer and coronavirus disease 2019: a systematic review and meta-analysis of cohort studies. Cancer. 2021;127(9):1459–1468.
  • Hungria V, Garnica M, de Queiroz Crusoe E, et al. Managing patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel – ABHH monoclonal gammopathies committee. Hematol Transfus Cell Ther. 2020;42(3):200–205.
  • International Myeloma Society recommendations for the management of myeloma patients during the COVID-19 pandemic. https://authorservices.wiley.com/asset/Author%20Guidelines%20Standard%20Reference%20Text.pdf. International Myeloma Society; c2020. [Cited August 14, 2020]. Available from: https://www.myelomasociety.org.
  • Schütt P, Brandhorst D, Stellberg W, et al. Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infections. Leuk Lymphoma. 2006;47(8):1570–1582.
  • Kristinsson SY, Tang M, Pfeiffer RM, et al. Monoclonal gammopathy of undetermined significant and risk of infections: a population-based study. Haematologica. 2012;97(6):854–858.
  • Chari A, Samur MK, Martinez-Lopez J, et al. Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the international myeloma society data set. Blood. 2020; 136(26):3033–3040. doi:
  • Milani P, Sanchorawala V, Lecumberri R, et al. Sars-Cov-2 infection and systemic light chain amyloidosis: the International Society of Amyloidosis’ Survey. 62nd American Society of Hematology Meeting and Exposition. December 5–8, 2020. Abstract #2308.
  • Richards M, Anderson M, Carter P, et al. The impact of the COVID-19 pandemic on cancer care. Nat Cancer. 2020; 1:1–567.
  • Balogun OD, Bea VJ, Phillips E. Disparities in cancer outcomes due to COVID-19-A Tale of 2 Cities. JAMA Oncol. 2020; 6(10):1531–1532.
  • Al Saleh A,S, Sher T, Gertz M. Multiple myeloma in the time of COVID-19. Acta Haematol. 2020;143(5):410–416.
  • Lai AG, Pasea L, Banerjee A, et al. Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study. BMJ Open. 2020;10(11):e043828.
  • Czeisler MÉ, Marynak K, Clarke KEN, et al. Delay or avoidance of medical care because of COVID-19-related concerns – United States, June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(36):1250–1257. doi: https://doi.org/http://dx.doi.org/10.15585/mmwr.mm6936a4external_icon.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.